Search results
Singapore. At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines investing in four core therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
- Search Jobs
Search Jobs - Singapore | GSK
- Manufacturing and Supply
Manufacturing and Supply - Singapore | GSK
- Media Contacts
Global headquarters (London, UK) Tim Foley, Vice President,...
- Quarterly Results
Discover our latest financial performance announcement and...
- London (Rns)
London (Rns) - Singapore | GSK
- Analyst Consensus
The consensus has been collated from estimates submitted by...
- New York (Sec)
Learn more about GSK announcements on the New York Stock...
- Debt Investors
Issuer Issue currency Issue amount (millions) Issue date...
- Search Jobs
GlaxoSmithKline (GSK) GSK’s first foray into Singapore was the construction of a world-class facility antibiotic manufacturing plant on a five-hectare site. Costing over S$32 million, it produced a range of newly discovered semi-synthetic penicillin.
Jul 13, 2023 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850...
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
Issued: 17 November 2022, Singapore GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments • S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more quickly
GSK’s latest investment is a strong show of confidence in Singapore’s world-class infrastructure and skilled workforce for biopharmaceutical manufacturing. In addition to efforts in developing manufacturing leaders in Singapore, GSK has also been a steadfast partner to our research ecosystem.
Nov 17, 2022 · Facility will manufacture a key ingredient for antibody drug conjugates (ADCs) GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
